leadf
logo-loader
AIM:FARN

Faron Pharmaceuticals Ltd

Receive alerts
Market:
AIM
Market Cap:
£165.12 m
Price
327.50 GBX
Change
-0.76%
52 weeks high
595.00
52 weeks low
216.05

In brief

Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline focusing on acute organ traumas, vascular damage and cancer immunotherapy.

Snapshot

  • Focuses on Clevegen and Traumakine
  • Clevegen in studies for several types of cancer
  • Traumakine being tested as a treatment for coronavirus in three trials